Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe Record History now lists Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry 'Revision: v3.5.0' has been added to the history. The entry for 'Revision: v3.4.3' has been removed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe history now includes Revision: v3.4.3 and no longer displays Revision: v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision history updated: added entry v3.4.2 and removed entry v3.4.1.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision v3.4.1 was added to the history, and revision v3.4.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.